Wang Yuan, Xu Wanchun, Mak Ivy Lynn, Chin Weng Yee, Yu Esther Yee Tak, Lam Cindy Lo Kuen, Wan Eric Yuk Fai
Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Department of Family Medicine, The University of Hong Kong - Shenzhen Hospital, Guangdong, China.
EClinicalMedicine. 2023 May 11;60:101999. doi: 10.1016/j.eclinm.2023.101999. eCollection 2023 Jun.
Diabetes mellitus-related characteristics, including available medications, onset ages, and newly-introduced management program, have been changing recently in Hong Kong, especially after the introduction of the Risk Assessment and Management Program-Diabetes Mellitus in all outpatient clinics in 2009. To understand the plural change and improve the management of patients with Type 2 Diabetes Mellitus (T2DM) based on the latest data, we examined the trends of clinical parameters, T2DM complications and mortality in patients with T2DM in Hong Kong from 2010 to 2019.
In this retrospective cohort study, we acquired data from the Clinical Management System of the Hospital Authority in Hong Kong. Among adults with T2DM diagnosed on or before Sept 30, 2010, and with at least one attendance in general outpatient clinics between Aug 1, 2009, to Sept 30, 2010, we investigated the age-standardised trends of clinical parameters including haemoglobin A1c, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol (LDL-C), body mass index and estimated glomerular filtration rate (eGFR), complications including cardiovascular disease (CVD), peripheral vascular disease (PVD), sight-threatening diabetic retinopathy (STDR), neuropathy, eGFR<45 mL/min/1.73 m and end-stage renal disease (ESRD), and all-cause mortality from 2010 to 2019 and tested the statistical significance of the trends using generalised estimating equation by sex, level of clinical parameters and age groups.
In total, 82,650 males and 97,734 females with T2DM were identified. LDL-C decreased from 3 to 2 mmol/L in both males and females, while other clinical parameters changed within 5% over the full decade from 2010 to 2019. CVD, PVD, STDR, and neuropathy had declining incidences, while ESRD and all-cause mortality had increasing incidences from 2010 to 2019. The incidence of eGFR<45 mL/min/1.73 m increased in males but decreased in females. The odds ratio (OR) of ESRD (1.13, 95% CI [1.12, 1.15]) was highest in both males and females while the ORs of STDR (0.94, 95% CI [0.92, 0.96]) and neuropathy (0.90, 95% CI [0.88, 0.92]) were lowest in males and females, respectively. Complications and all-cause mortality trends varied among baseline HbA1c, eGFR, and age subgroups. In contrast to the findings in other age groups, the incidence of any outcomes did not decrease in younger patients (<45 years) from 2010 to 2019.
Improvements were observed in LDL-C and incidences of most complications from 2010 to 2019. Worse performance in the younger age group and increasing incidence of renal complications and mortality need more attention in managing patients with T2DM.
The Health and Medical Research Fund, the Health Bureau, and Government of the Hong Kong Special Administrative Region.
与糖尿病相关的特征,包括可用药物、发病年龄和新推出的管理方案,近年来在香港一直在变化,特别是在2009年所有门诊诊所引入糖尿病风险评估与管理方案之后。为了基于最新数据了解这些多元变化并改善2型糖尿病(T2DM)患者的管理,我们研究了2010年至2019年香港T2DM患者的临床参数、T2DM并发症及死亡率的趋势。
在这项回顾性队列研究中,我们从香港医院管理局的临床管理系统获取数据。在2010年9月30日及以前诊断为T2DM,且在2009年8月1日至2010年9月30日期间至少在普通门诊就诊一次的成年人中,我们调查了临床参数(包括糖化血红蛋白、收缩压、舒张压、低密度脂蛋白胆固醇(LDL-C)、体重指数和估算肾小球滤过率(eGFR))、并发症(包括心血管疾病(CVD)、外周血管疾病(PVD)、威胁视力的糖尿病视网膜病变(STDR)、神经病变、eGFR<45 mL/min/1.73 m²和终末期肾病(ESRD))以及2010年至2019年全因死亡率的年龄标准化趋势,并使用广义估计方程按性别、临床参数水平和年龄组检验趋势的统计学意义。
共识别出82,650例男性和97,734例女性T2DM患者。男性和女性的LDL-C均从3 mmol/L降至2 mmol/L,而其他临床参数在2010年至2019年的整个十年间变化幅度在5%以内。2010年至2019年,CVD、PVD、STDR和神经病变的发病率下降,而ESRD和全因死亡率的发病率上升。男性中eGFR<45 mL/min/1.73 m²的发病率上升,女性中则下降。ESRD的优势比(OR)(1.13,95%置信区间[1.12, 1.15])在男性和女性中均最高,而STDR(0.94,95%置信区间[0.92, 0.96])和神经病变(0.90,95%置信区间[0.88, 0.92])的OR在男性和女性中分别最低。并发症和全因死亡率趋势在基线糖化血红蛋白、eGFR和年龄亚组中有所不同。与其他年龄组的结果相反,2010年至2019年年轻患者(<45岁)中任何结局的发病率均未下降。
2010年至2019年期间,LDL-C及大多数并发症的发病率有所改善。年轻年龄组的较差表现以及肾脏并发症和死亡率的上升在T2DM患者管理中需要更多关注。
香港特别行政区政府卫生署健康及医学研究基金。